| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11014876 | The Journal of Heart and Lung Transplantation | 2018 | 29 Pages |
Abstract
Our data suggest that intravenous treprostinil via the LENUS Pro pump in advanced PH is associated with a very low risk of bloodstream infections, but other serious adverse events may occur. Therefore, this therapy needs standardization and should be offered in specialized PH centers only. Further technical advances of the pump system and prospective studies are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Manuel J. MD, Satenik MD, Tom MD, Simon MD, Henning MD, PhD, Felix Gerhardt, MD, Friedrich MD, PhD, Jan Grimminger, Ekkehard MD, Stefan MD, Michael MD, Alexander MD, Marius M. MD, Hans MD, Tobias J. MD, Katrin MD, Claus MD, Kai MD, Ralf MD,